Financing channel feed – Endpoints News

Financing channel feed

Daphne Koller’s AI startup gets $143M in new cash from a16z, others

6 years ago

As biotech IPOs sizzle on virtual Wall Street, 3 new players roll the dice on megamoney gambles topping $325M

6 years ago

Ex-Axovant crew at Arvelle ups Series A haul, deploying $200M-plus to commercialize epilepsy drug in Europe

6 years ago

After years of partnerships, AI biotech Exscientia lands first major financing round at $60M

6 years ago

Bezos, Paul Allen funds, a16z put up $100M to build an Illumina of human proteins

6 years ago

Pharmasset co-founder jumps into Covid-19 fight, with a new company and $215 million to get there

6 years ago

Andreessen Horowitz backs a new molecule builder from UCLA equipped with the latest in convergence tech. And he’s aiming big

6 years ago

A little-known biotech running low on cash looks to get its own $100M IPO from pandemic market

6 years ago

Flush with $165M IPO cash, Zentalis entices Tybourne, OrbiMed to fund a $20M China joint venture

6 years ago

Ally Bridge joins Bain in $120M bet that speeding up manufacturing QC can hit big in post-pandemic world

6 years ago

'Tis the season for biopharma fundraising, as Cowen closes $493M fund

6 years ago

With bucks from Pfizer added to their new round, Amplyx steers a tricky course through PhII and a global pandemic

6 years ago

Martin Mackay’s rare disease startup gets $145 million as it enters the clinic

6 years ago

Two years in, Hong Kong’s biotech experiment has been validated

6 years ago

Sweden's Calliditas seeks $75M IPO haul to bring its oral steroid to patients with an orphan kidney disease

6 years ago

Bob Langer-founded cell therapy player loads up $65M to fund Roche-partnered cancer work while expanding into vaccines for infectious diseases

6 years ago

ADC steams back to virtual Wall Street — and this time the team scores a $233M IPO haul

6 years ago

Stanford, Parker Institute scientists team up with two young engineers in $20M AI play with an immunology focus

6 years ago

BCMA rival to bluebird, Bristol Myers files for $100M IPO as the frontrunners stumble in a race to the finish line

6 years ago

Precision therapy approach secures small biotech $42M haul to combat disease that inspired the Ice Bucket Challenge

6 years ago

With money flowing, Pliant Therapeutics heads to public well

6 years ago

Vivek Ramaswamy’s brother, Shankar, spins out on his own, launching audacious gene therapy play

6 years ago

Blood test for cancer detection company Grail rakes in $390M in latest round

6 years ago

'It's pure art': Versant, GV reveal $60M bet that a clearer look at inflammasomes can lead to better drugs

6 years ago

First page Previous page 99 100 101102103 104 105 Next page Last page